MedTrace Logo

Seasonal Allergic Rhinitis Study

NCT01123252 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-08-23

No results posted yet for this study

Summary

The study aims to examine the effect of probiotics on the clinical symptoms of allergic rhinitis and to elucidate some of the immunological mechanisms involved.

Conditions

  • Seasonal Affective Rhinitis
  • Asthma
  • Grass Allergy

Interventions

DIETARY_SUPPLEMENT

Lactobacillus casei Shirota (LcS)

Subjects will receive one bottle of Yakult containing the probiotic bacterium Lactobacillus casei Shirota (active drink) once daily for 4 months (16 weeks).

DIETARY_SUPPLEMENT

Placebo

Subjects will receive one bottle of a placebo milk drink, once daily for 4 months (16 weeks).

Sponsors & Collaborators

  • Quadram Institute Bioscience

    collaborator OTHER

  • Norfolk and Norwich University Hospitals NHS Foundation Trust

    collaborator OTHER

  • Yakult Honsha Co., LTD

    collaborator INDUSTRY

  • University of East Anglia

    lead OTHER

Principal Investigators

  • Andrew Wilson · University of East Anglia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01123252 on ClinicalTrials.gov